Associated Papers
Polydatin and Nicotinamide Prevent Iron Accumulation and Lipid Peroxidation in Cellular Models of Mitochondrial Diseases.
Cilleros-Holgado P et al.
Antioxidants (basel, Switzerland), 2025
Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation.
Cilleros-Holgado P et al.
Biomolecules, 2024
UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases.
Suárez-Rivero JM et al.
Orphanet Journal of Rare Diseases, 2022
Clinical, neuroimaging and biochemical findings in patients and patient fibroblasts expressing ten novel GFM1 mutations.
Barcia G et al.
Human Mutation, 2020
Genes and Variants Underlying Human Congenital Lactic Acidosis-From Genetics to Personalized Treatment.
Bravo-Alonso I et al.
Journal of Clinical Medicine, 2019
Generation of a human iPSC line from a patient with a mitochondrial encephalopathy due to mutations in the GFM1 gene.
Zurita-Díaz F et al.
Stem Cell Research, 2016
Long-term survival in a child with severe encephalopathy, multiple respiratory chain deficiency and GFM1 mutations.
Brito S et al.
Frontiers in Genetics, 2015
Select a paper to view details